Freda C Lewis Hall is Director of EXACT SCIENCES CORP. Currently has a direct ownership of 19,688 shares of EXAS, which is worth approximately $1.4 Million. The most recent transaction as insider was on Jun 08, 2023, when has been sold 3,599 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.7K
0% 3M change
0% 12M change
Total Value Held $1.4 Million

Freda C Lewis-Hall Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 08 2023
BUY
Grant, award, or other acquisition
-
3,599 Added 15.45%
19,688 Common Stock
Jun 09 2022
BUY
Grant, award, or other acquisition
-
5,606 Added 25.84%
16,089 Common Stock
Jun 30 2021
BUY
Grant, award, or other acquisition
-
2,011 Added 16.1%
10,483 Common Stock

Also insider at

PFE
PFIZER INC Healthcare
SWTX
SpringWorks Therapeutics, Inc. Healthcare
ONEM
1Life Healthcare Inc Healthcare
PYXS
Pyxis Oncology, Inc. Healthcare
MURF
Murphy Canyon Acquisition Corp. Financial Services
FCL

Freda C Lewis Hall

Director
New York, NY

Track Institutional and Insider Activities on EXAS

Follow EXACT SCIENCES CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EXAS shares.

Notify only if

Insider Trading

Get notified when an Exact Sciences Corp insider buys or sells EXAS shares.

Notify only if

News

Receive news related to EXACT SCIENCES CORP

Track Activities on EXAS